Eliminate now: Seven critical actions required to accelerate elimination of Plasmodium falciparum malaria in the Greater Mekong Subregion

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Lover, Andrew A ^a   Gosling, Roly ^a   Feachem, Richard ^a   Tulloch, Jim ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE;

ARTICLE; DISEASE ELIMINATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MALARIA CONTROL; MALARIA FALCIPARUM; NONHUMAN; OUTCOME ASSESSMENT; PLASMODIUM FALCIPARUM; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; SOCIAL BEHAVIOR; SOCIAL SUPPORT; SOUTHEAST ASIA; ASIA; DISEASE ERADICATION; MALARIA, FALCIPARUM; ORGANIZATION AND MANAGEMENT; PROCEDURES;

ASIA; DISEASE ERADICATION; HUMANS; MALARIA, FALCIPARUM;

EID: 84992176885     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-016-1564-3     Document Type: Article

References (35)

1. WHO. Emergency response to artemisinin resistance in the Greater Mekong Subregion. Regional framework for action 2013-2015. Geneva: World Health Organization; 2013. p. 32. http://www.who.int/malaria/publications/atoz/9789241505321/en/.
2. WHO, DFID, USAID/PMI. Joint assessment of the response to artemisinin resistance in the Greater Mekong sub-region conducted November 2011 to February 2012-summary report; 2012. http://whothailand.healthrepository.org/bitstream/123456789/1484/3/120418-Artemisinin-Resistance-in-GMS-SummaryReport.pdf.
3. Miotto O, Almagro-Garcia J, Manske M, MacInnis B, Campino S, Rockett KA, et al. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nat Genet. 2013;45:648-55.
4. Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415-21.
5. Djimde AA, Makanga M, Kuhen K, Hamed K. The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine. Expert Rev Anti Infect Ther. 2015;13:1031-45.
6. Leang R, Taylor WRJ, Bouth DM, Song L, Tarning J, Char MC, et al. Evidence of Plasmodium falciparum malaria multidrug resistance to artemisinin and piperaquine in Western Cambodia: dihydroartemisinin-piperaquine open-label multicenter clinical assessment. Antimicrob Agents Chemother. 2015;59:4719-26.
7. Gueye CS, Newby G, Hwang J, Phillips AA, Whittaker M, MacArthur JR, et al. The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion. Malar J. 2014;13:286.
8. Wang SS. A warning from the heart of malaria research. Wall Str. J. http://www.wsj.com/articles/a-warning-from-the-heart-of-malaria-research-1423506898. Accessed from 9 Feb 2015.
9. WHO. International health regulations (2005): [internet], 2nd edn. Geneva: World Health Organization; 2008. http://www.who.int/ihr/publications/9789241596664/en/.
10. Heymann DL, Hodgson A, Freedman DO, Staples JE, Althabe F, Baruah K, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet. 2016;387:719-21.
11. MalariaGEN Plasmodium falciparum community project. Genomic epidemiology of artemisinin resistant malaria. eLife. 2016; 5:e08714.
12. Trape JF. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64:12-7.
13. Slater HC, Griffin JT, Ghani AC, Okell LC. Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa. Malar J. 2016;15:10.
14. Anderson RM, Fraser C, Ghani AC, Donnelly CA, Riley S, Ferguson NM, et al. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004;359:1091-105.
15. Foster SO, Ward NA, Joarder AK, Arnt N, Tarantola D, Rahman M, et al. Smallpox surveillance in Bangladesh: development of surveillance containment strategy. Int J Epidemiol. 1980;9:329-34.
16. WHO. Report of the Fourth Meeting of the Anti-Malaria Coordination Board of Burma, Cambodia, Laos, the Federation of Malaya, Thailand and Viet-Nam (1959). Geneva: World Health Organization; 1960. WHO/Mal/250. http://whqlibdoc.who.int/malaria/WHO-Mal-250.pdf.
17. Pampana E. A textbook of malaria eradication. 2nd ed. London: Oxford University Press; 1969.
18. Meek S, Pearson M, Westberg L, Tate J, Dunn KC. An overview of antimalarial commodity issues in the Asia Pacific region. 2014. https://www.aplma.org/upload/resource/Papers/overview%20of%20antimalarial%20commodity%20issues%20in%20the%20asia%20pacific%20region.pdf. Accessed 4 Jul 2016.
19. Canavati SE, Lawpoolsri S, Quintero CE, Nguon C, Ly P, Pukrittayakamee S, et al. Village malaria worker performance key to the elimination of artemisinin-resistant malaria: a Western Cambodia health system assessment. Malar J. 2016;15:282.
20. Kyaw SS, Drake T, Thi A, Kyaw MP, Hlaing T, Smithuis FM, et al. Malaria community health workers in Myanmar: a cost analysis. Malar J. 2016;15:41.
21. Kamal-Yanni MM, Potet J, Saunders PM. Scaling-up malaria treatment: a review of the performance of different providers. Malar J. 2012;11:414.
22. Cox J, Sovannaroth S, Dy Soley L, Ngor P, Mellor S, Roca-Feltrer A. Novel approaches to risk stratification to support malaria elimination: an example from Cambodia. Malar J. 2014;13:371.
23. Kok MC, Dieleman M, Taegtmeyer M, Broerse JE, Kane SS, Ormel H, et al. Which intervention design factors influence performance of community health workers in low- and middle-income countries? A systematic review. Health Policy Plan. 2015;30:1207-27.
24. Melgaard B, Creese A, Aylward B, Olive JM, Maher C, Okwo-Bele JM, et al. Disease eradication and health systems development. Bull World Health Organ. 1998;76:26-31.
25. Eichler R, Levine R. Performance incentives for global health: potential and pitfalls. 1st ed. Washington, DC: Center for Global Development Books; 2009.
26. Gosling J, Case P, Tulloch J, Chandramohan D, Wegbreit J, Newby G, et al. Effective program management: a cornerstone of malaria elimination. Am J Trop Med Hyg. 2015;93:135-8.
27. Garcia R, Hewitt S, Tulloch J. Report of the independent review of the Global Fund Regional Artemisinin-resistance Initiative (RAI). Geneva: The Global Fund; 2015.
28. Greenough P. Intimidation, coercion and resistance in the final stages of the South Asian Smallpox Eradication Campaign, 1973-1975. Soc Sci Med. 1995;41:633-45.
29. Henderson DA. Principles and lessons from the smallpox eradication programme. Bull World Health Organ. 1987;65:535.
30. Gladwell M. Fred Soper and the global malaria eradication programme. J Public Health Policy. 2002;23:479-97.
31. Nájera JA. Some Lessons from the Malaria Eradication Campaign [internet]. Mahidol, Bangkok; 2010. http://www.tm.mahidol.ac.th/jitmm-2010/download/JITMM-1-12-2010-IMC6-Jose.pdf.
32. Bruce-Chwatt LJ. Essential malariology. 2nd ed. New York: Wiley; 1985.
33. Zhao J, Lama M, Sarkar S, Atun R. Indicators measuring the performance of malaria programs supported by the global fund in Asia, progress and the way forward. PLoS ONE. 2011;6:e28932.
34. Soper FL, Wilson DB. Anopheles gambiae in Brazil 1930 to 1940. 1st ed. New York: The Rockefeller Foundation; 1943.
35. World Health Organization. WHO updates on artemisinin resistance [internet]. http://www.who.int/malaria/areas/drug-resistance/updates/en/. Accessed 5 Aug 2016.